Health-related quality of life in the randomised KEYNOTE-002 study of pembrolizumab versus chemotherapy in patients with ipilimumab-refractory melanoma

Published 2016 View Full Article

  1. Home
  2. Publications
  3. Publication Search
  4. Publication Details
Title
Health-related quality of life in the randomised KEYNOTE-002 study of pembrolizumab versus chemotherapy in patients with ipilimumab-refractory melanoma
Authors
Keywords
Pembrolizumab, Patient-reported outcomes, Health-related quality of life, KEYNOTE-002, Advanced melanoma, Ipilimumab-refractory melanoma, Chemotherapy, EORTC QLQ-C30
Journal
EUROPEAN JOURNAL OF CANCER
Volume 67, Issue -, Pages 46-54
Publisher
Elsevier BV
Online
2016-09-04
DOI
10.1016/j.ejca.2016.07.018

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now
Webinars Posters Questions Hubs Funding Journals Articles Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.